Friday, February 22, 2013

• EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM AB AS COMETRIQ (TM) EUROPEAN DISTRIBUTOR FOR MEDULLARY THYROID CANCERThomson Reuters ONE (Fri, Feb 22)

Thursday, February 21, 2013

• Exelixis' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Feb 21)
• Exelixis Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet (Thu, Feb 21)
• Exelixis, Inc. Earnings Call scheduled for 5:00 pm ET todayCCBN (Thu, Feb 21)
• Exelixis Selects Swedish Orphan Biovitrum AB as COMETRIQ™ European Distributor for Medullary Thyroid CancerBusiness Wire (Thu, Feb 21)
• EXELIXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Feb 21)
• Exelixis Announces Fourth Quarter and Full Year 2012 Financial ResultsBusiness Wire (Thu, Feb 21)
• Celgene's New Acquisition -- of Celgeneat Motley Fool (Thu, Feb 21)
• EXELIXIS, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Thu, Feb 21)
• Q4 2012 Exelixis, Inc. Earnings Release - After Market CloseCCBN (Thu, Feb 21)

Tuesday, February 19, 2013

• 5 Can't-Miss Health-Care Events This Weekat Motley Fool (Tue, Feb 19)
• Four Biotech Stocks On The Clockat Seeking Alpha (Tue, Feb 19)

Friday, February 15, 2013

• 5 Reasons to Worry About Next Weekat Motley Fool (Fri, Feb 15)

Friday, February 8, 2013

• Exelixis execs win bonuses, pay boosts as first cancer drug hits marketat bizjournals.com (Fri, Feb 8)
• EXELIXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online (Fri, Feb 8)

Thursday, February 7, 2013

• Exelixis Announces February 21st Webcast of Fourth Quarter and Full Year 2012 Financial Results Conference CallBusiness Wire (Thu, Feb 7)

Wednesday, February 6, 2013

• Exelixis Announces Webcast of February 12th Presentation at the 15th Annual BIO CEO & Investor ConferenceBusiness Wire (Wed, Feb 6)

Saturday, February 2, 2013

• What's Ahead for Exelixis?at Motley Fool (Sat, Feb 2)

Thursday, January 31, 2013

• Prognosis Positive: Medical Growth Stocks to Watchat Motley Fool (Thu, Jan 31)

Wednesday, January 30, 2013

• Revisiting Exelixis And Cabozantinibat Seeking Alpha (Wed, Jan 30)
• Buy, Sell, or Hold: Peregrine Pharmaceuticalsat Motley Fool (Wed, Jan 30)

Friday, January 25, 2013

• Here's a Basket of Potentially Explosive Growthat Motley Fool (Fri, Jan 25)
• EXELIXIS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Fri, Jan 25)

Thursday, January 24, 2013

• Exelixis Announces COMETRIQ™ (cabozantinib) Is Now Available in the U.S.Business Wire (Thu, Jan 24)

Wednesday, January 23, 2013

• Biotech: Core and Exploreat Motley Fool (Wed, Jan 23)

Add EXEL News to My Yahoo!